Linear IgA bullous dermatosis treated with rituximab
Authors:
Open Access
- 1 February 2019
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 5 (2) , 124-126
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Rituximab Treatment for Recalcitrant Dermatitis HerpetiformisJAMA Dermatology, 2017
- Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including RituximabJAMA Dermatology, 2015
- [Rituximab (Mabthera) for treatment of rare autoimmune bullous skin disorders].2012
- IgA-mediated epidermolysis bullosa acquisita: Two cases and review of the literatureJournal of the American Academy of Dermatology, 2002
- Drug-induced linear IgA disease: target antigens are heterogeneous.1997
- Drug-induced linear IgA disease: target antigens are heterogeneousBritish Journal of Dermatology, 1997
- Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.1995
- Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French RegionsArchives of Dermatology, 1995